
Adbry Coupons & Discount Card - Compare Prices Near You
My prescription
Edit
2 solution prefilled syringes 1ML of 150MG/ML, Adbry (1 Syringe)
Select pharmacy

Walgreens
$1048.00
COUPON PRICEAdbry savings card
Show this card to your pharmacist
Walgreens
$1048.00
BIN
ID
PCN
GRP
019876
LH618E1A67
CHIPPO
LHX
Powered by
Related monoclonal antibodies prescriptions
More prescriptions for eczema
Related monoclonal antibodies prescriptions
More prescriptions for eczema
Adbry dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
2 solution prefilled syringes 1ML of 150MG/ML | 1 Syringe | $1027.23 | $1027.23 |
Adbry Warnings
This section provides crucial safety information about the use of Adbry (tralokinumab). Please read carefully and consult with your healthcare provider if you have any questions or concerns.
Risk of Serious Allergic Reactions: Using Adbry (tralokinumab) may result in severe allergic reactions, including potentially life-threatening anaphylaxis. If you experience symptoms such as throat constriction, difficulty breathing, dizziness, sweating, nausea, or swelling around the eyes, lips, or tongue, seek immediate medical attention.
Eye-Related Side Effects: Adbry (tralokinumab) can lead to conditions like conjunctivitis (pink eye) or eye inflammation. Most individuals find these issues resolve over time. Should you notice any changes in vision, blurred vision, irritation, or itchy and watery eyes, consult your dermatologist or optometrist promptly.
Infection Risk: The impact of Adbry (tralokinumab) on the immune system's ability to fight certain infections, such as parasitic infections, is not fully understood. It is important to inform your dermatologist of any existing infections before starting treatment. If you develop an infection while on Adbry (tralokinumab) and do not respond to antiparasitic treatment, discontinuation of the medication may be necessary until the infection clears.
Vaccination Precaution: You should avoid live vaccines while taking Adbry (tralokinumab), as their safety is not established in this context. Live vaccines include those for chickenpox (Varivax) and measles, mumps, and rubella (MMR). Ensure your vaccinations are up to date before beginning treatment with Adbry (tralokinumab). Inform your healthcare provider or pharmacist about your current medication regimen prior to receiving any vaccines.
No specific contraindications have been identified for the use of Adbry (tralokinumab).
Adbry Side Effects
When taking this medication, some individuals may experience common side effects such as upper respiratory infections, pink eye, and reactions at the injection site, including pain, redness, and swelling. These effects are generally mild, but if they persist or worsen, it's advisable to consult with a healthcare provider.
Occasionally, users might notice an increase in eosinophil levels, a type of white blood cell. While this is not a common occurrence, monitoring by a healthcare provider is recommended if it arises.
There are also rare but serious side effects that necessitate immediate medical attention. These include severe allergic reactions, which may present as difficulty breathing, hives, or swelling of the face, lips, tongue, or throat. Additionally, symptoms of infection such as fever, persistent cough, difficulty breathing, diarrhea, weakness, sweating, chills, or skin issues like scaly, itchy, or burning sensations should prompt urgent care.
While the list above covers many potential side effects, it's not exhaustive. If you experience any unlisted effects or have concerns, reaching out to a healthcare professional is a good course of action.
What is the drug adbry used for?
Adbry is used for the treatment of moderate-to-severe atopic dermatitis in adults whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
What's the difference between Dupixent and adbry?
Dupixent (dupilumab) and Adbry (tralokinumab) are both monoclonal antibodies used to treat moderate-to-severe atopic dermatitis, but they target different interleukins. Dupixent inhibits interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling, while Adbry specifically targets interleukin-13 (IL-13). The choice between them may depend on individual patient response, side effect profiles, and specific clinical considerations.
Is adbry a high risk medication?
Adbry (tralokinumab-ldrm) is not generally considered a high-risk medication. It is a monoclonal antibody used for the treatment of moderate-to-severe atopic dermatitis in adults. Like all medications, it may have side effects, but it is not classified as high-risk. Patients should follow their healthcare provider's instructions and report any unusual symptoms.
Can you take adbry and Dupixent together?
It is important for patients to consult their healthcare provider before taking Adbry and Dupixent together. Both medications are used to treat similar conditions, and a healthcare provider can determine the best treatment plan based on the patient's specific medical history and needs.
What is adbry used to treat?
Adbry is used to treat moderate-to-severe atopic dermatitis in adults whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.